# A Phase IIa Study in Primary IgA Nephropathy Patients

> **NCT07634744** · PHASE2 · COMPLETED · sponsor: **Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.** · enrollment: 25 (actual)

## Conditions studied

- IgA Nephropathy

## Interventions

- **DRUG:** XH-S003 Capsule

## Key facts

- **NCT ID:** NCT07634744
- **Lead sponsor:** Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-31
- **Primary completion:** 2026-04-23
- **Final completion:** 2026-04-23
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07634744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07634744, "A Phase IIa Study in Primary IgA Nephropathy Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07634744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*